Detalhe da pesquisa
1.
Prognostic value of pathological nodal burden after neoadjuvant chemotherapy in initially cN0-1 breast cancer patients: a dual-center, 10-year survival analysis.
Ther Adv Med Oncol
; 16: 17588359241248318, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38716480
2.
A nomogram for predicting pathologic node negativity after neoadjuvant chemotherapy in breast cancer patients: a nationwide, multicenter retrospective cohort study (CSBrS-012).
Front Oncol
; 14: 1326385, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38800388
3.
Effect of HER2-low-positive status on neoadjuvant chemotherapy and survival outcome of breast cancer: a 10-year dual-center retrospective study.
Am J Cancer Res
; 13(8): 3571-3581, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37693150
4.
Efficacy analysis of neoadjuvant chemotherapy with or without anthracyclines in female patients with HER2-positive breast cancer in China: a nationwide, multicenter, 10-year retrospective study (CSBrS-012).
Ther Adv Med Oncol
; 15: 17588359231156146, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36891484
5.
Nomogram for predicting axillary upstaging in clinical node-negative breast cancer patients receiving neoadjuvant chemotherapy.
J Cancer Res Clin Oncol
; 149(11): 8769-8778, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37129606
6.
Prevalence of BRCA1 and BRCA2 gene mutations in Chinese patients with high-risk breast cancer.
Mol Genet Genomic Med
; 7(6): e677, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30968603
7.
Analysis of factors related to non-sentinel lymph node metastasis in 296 sentinel lymph node-positive Chinese breast cancer patients.
Cancer Biol Med
; 15(3): 282-289, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30197795
8.
Erratum to Analysis of factors related to non-sentinel lymph node metastasis in 296 sentinel lymph node-positive Chinese breast cancer patients.
Cancer Biol Med
; 15(4): 478, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30766758